Technology companies around the world are racing to show the latest scientific innovations that represent great opportunities to change the world, including what the company, "Neuralink", revealed to its founder, Elon Musk, that it is working to help treat neurological diseases through wireless chips implanted in the brain.
The company is taking an advanced step by starting clinical trials, through its search at the present time for a director of clinical trials in order to undertake work with doctors and engineers to develop these slides.
According to the "Daily Mail", the Neuralink company's system consists of a chip attached to fine flexible threads that are connected in the brain by a robot. The device receives signals in the brain that are then translated.
In one of his interviews, Elon Musk explained that the company works well with monkeys and that they do a lot of experiments, stressing that it is very safe and reliable, and that the only reason it has not been tested on humans is the lack of approval of the US Food and Drug Administration.
"Our standards for implantation are higher than what the FDA approves, just as our safety standards are much higher than what the US government requires," Musk said, describing the technology as key to helping paraplegics walk, treating depression and a way to integrate humans with computers.
Musk continued: “We hope to have this in humans, who have severe spinal cord injuries, who are quadriplegics, I think we have an opportunity to be able to allow someone who cannot walk or use their arms to be able to walk or move again, but Not naturally.”
Okaz (Agencies)
